4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001470831-26-000819
Options or other derivatives
- Chief Financial Officer acquired 285,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Larson Jennifer · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-12 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +285,000 | 285,000 | D |
Loading xslF345X06/wk-form4_1786740871.xml…